Skip to main content
Premium Trial:

Request an Annual Quote

Trevor Hawkins, John Rogers, David Cooper, Adrian Dillon, Edward Barnholt, Mark Gardner, Nina Federoff, David Harvey, W. Lee McCollum, William O Neil, Jr., J. Pedro Reinhard, D. Dean Spatz, Barrett Toan, Paul Berg, Walter Gilbert, Frederick Sanger

MDS announced last week that Trevor Hawkins, GE Healthcare's former president of molecular diagnostics, will join the company as its new chief science and technology officer. In this newly created position, Hawkins will focus on "identifying technologies, strategic initiatives and alliances that will leverage the company's existing technology and provide new market opportunities," MDS said in a statement. He started the job on May 2 and will report to CEO John Rogers.

Before joining GE, Hawkins was the senior vice president of development and new business initiatives at Amersham Biosciences. Hawkins has also directed the US Department of Energy's Human Genome Project at the Joint Genome Institute.He has a PhD in biochemistry from the University of Sussex/MRC Laboratory of Molecular Biology and a BS from the Universityof Sussex.


David Cooper has been named senior vice president, finance, and treasurer at Agilent Technologies. Cooper will report to Adrian Dillon, CFO and executive vice president of finance and administration. He most recently served as CFO of QRS, a collaborative services and software provider.

Former Agilent Technologies CEO Edward Barnholt has been named to the board of directors of eBay, the online auctioneer said last week. Barnholt stepped down as CEO of Agilent in March.


Mark Gardner has been promoted to the post of chief marketing officer of Invitrogen. He most recently served as vice president of commercial marketing for the firm. Gardnerjoined Invitrogen in 2003 from GE Medical Systems, and previously was a McKinsey & Co. consultant.

The shareholders of Sigma-Aldrich re-elected Nina Federoff, David Harvey, W. Lee McCollum, William O'Neil, Jr., J. Pedro Reinhard, D. Dean Spatz, and Barrett Toan to the firm's board of directors.


Nobel laureate Paul Berg, professor emeritus of cancer research at StanfordUniversityand director emeritus for the Beckman Center for Molecular and Genetic Medicine, will receive the Biotechnology Heritage award to be presented by the Chemical Heritage Foundation and the Biotechnology Industry Organization at BIO 2005 in Philadelphia, the organizations said last week. Berg, along with Walter Gilbert and Frederick Sanger, received the 1980 Nobel Prize in chemistry for developing methods that make it possible to map the structure and function of DNA.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.